Didier Hoch
Vermögen: 107 157 $ am 31.05.2026
Vermögen: 107 157 $ am 31.05.2026
Didier Hoch is the founder of Big Booster'S (2014).
Current jobs include Co-Chairman at Underground Charity Foundation (2018), Chairman at PHAXIAM Therapeutics SA (2023), Director at Fondation Universite Grenoble Alpes, Director at Goliver Therapeutics, and Independent Member-Supervisory Board at Myasterix.
Former jobs include Chairman & Chief Executive Officer at Pherecydes Pharma SA (2022), Chairman at MSD Vaccines Ltd. (2010), Chairman at Sanofi Pasteur SA (2000-2010), Non-Executive Chairman at Pevion Biotech AG (2011-2013), Chairman at BioVision (2013-2018), Chairman at Fondation pour l’Université de Lyon (2014-2018), Chairman at OSE Immunotherapeutics SA (2024-2025), Director at DBV Technologies SA (2012-2016), Independent Director at ERYTech Pharma SA, Independent Director at Effimune SA, Independent Director at Germitec SA (2014-2019), Vice President at Rhone Poulenc Rorer (2000-2009), President at European Vaccine Manufacturers (2009-2010), Member-Supervisory Board at Genticel SA (2014-2017), President-Life Science Health Committee at Mouvement des Entreprises de France, and Vice President-Africa & Middle East Region at Aventis Pharma International SAS. Education includes an undergraduate degree from ESCP Europe Campus Paris and a doctorate from the University of Lyon (1984).
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.09.2025 | 20.965 ( 0,09 % ) | 107 157 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Vorsitzender | 23.06.2023 |
Goliver Therapeutics | Direktor/Vorstandsmitglied | - |
Fondation Universite Grenoble Alpes
Fondation Universite Grenoble Alpes Miscellaneous Commercial ServicesCommercial Services Operates as a public research university | Direktor/Vorstandsmitglied | - |
Underground Charity Foundation | Vorsitzender | 01.01.2018 |
Myasterix | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Vorsitzender | 30.09.2025 |
Germitec SA
Germitec SA Medical SpecialtiesHealth Technology Manufactures UV-C disinfection devices | Direktor/Vorstandsmitglied | 01.01.2019 |
Fondation pour l’Université de Lyon | Vorsitzender | 02.01.2018 |
BioVision | Vorsitzender | 01.01.2018 |
| ░░░ ░░░░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 24 |
|---|---|
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Manufactures and distributs pharmaceutical products. | Process Industries |
DBV Technologies SA
DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
MSD Vaccines Ltd.
MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and supplies vaccines | Health Technology |
ESCP Europe Campus Paris
ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Manufactures and supplies vaccines | Health Technology |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Health Technology |
European Vaccine Manufacturers | |
University of Lyon
University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genticel SA
Genticel SA BiotechnologyHealth Technology Develops vaccines for patients infected with human papillomavirus | Health Technology |
Mouvement des Entreprises de France
Mouvement des Entreprises de France Miscellaneous Commercial ServicesCommercial Services Operates network entrepreneurs | Commercial Services |
Effimune SA
Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Health Technology |
Pherecydes Pharma SA
Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
Germitec SA
Germitec SA Medical SpecialtiesHealth Technology Manufactures UV-C disinfection devices | Health Technology |
BioVision | |
Myasterix | |
Fondation pour l’Université de Lyon | |
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Aventis Pharma International SAS | |
Underground Charity Foundation | |
Fondation Universite Grenoble Alpes
Fondation Universite Grenoble Alpes Miscellaneous Commercial ServicesCommercial Services Operates as a public research university | Commercial Services |
Goliver Therapeutics | |
Big Booster'S
Big Booster'S Miscellaneous Commercial ServicesCommercial Services Provides acceleration program services for digital, environment and healthcare | Commercial Services |
PHAXIAM Therapeutics SA
PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen